{
     "PMID": "23769892",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20151103",
     "LR": "20141016",
     "IS": "1873-7544 (Electronic) 0306-4522 (Linking)",
     "VI": "248",
     "DP": "2013 Sep 17",
     "TI": "Effect of maternal deprivation on acetylcholinesterase activity and behavioral changes on the ketamine-induced animal model of schizophrenia.",
     "PG": "252-60",
     "LID": "10.1016/j.neuroscience.2013.05.059 [doi] S0306-4522(13)00492-2 [pii]",
     "AB": "Maternal deprivation has been associated with physiological and developmental changes that may be related to an increased risk for childhood and adult neuropsychiatric diseases. A growing number of studies demonstrated the importance of childhood experiences in the development of psychosis and schizophrenia in adulthood. Therefore, the present study investigated different behavior responses in rats following maternal deprivation and/or ketamine treatment in adulthood. Male rats were subjected to maternal deprivation for 180 min from postnatal day-01 to postnatal day-10. We evaluated locomotor activity, avoidance task and social interaction of adult male rats deprived or not deprived that were administered with saline or acute subanesthetic doses of ketamine (5, 15 and 25 mg/kg, i.p.). Our results show that only ketamine (25 mg/kg, i.p.) treatment in the adult rats lead to hyperlocomotion but not ketamine (5 and 15 mg/kg) and maternal deprivation alone. However, maternally deprived rats treated with ketamine (5 mg/kg) induced hyperlocomotion. Additionally, ketamine (25 mg/kg) and maternal deprivation alone induced cognitive deficit in the avoidance task. Rats deprived of and treated with ketamine (5, 15 and 25 mg/kg) also lead to memory deficit. Moreover, ketamine (25 mg/kg) and maternal deprivation alone increased latency to start social behavior. However, ketamine (5 mg/kg) and maternal deprivation lead to an increase of latency to start social behavior. Biochemistry data showed that all doses of ketamine and ketamine plus maternal deprivation increased the acetylcholinesterase (AChE) activity in the prefrontal cortex, hippocampus and striatum. The major doses of ketamine associated with maternal deprivation induced a major increase of AChE activity. Together, our results suggest that animals subjected to maternal deprivation had an increased risk for schizophrenia-like behavior and cholinergic alteration.",
     "CI": [
          "Copyright (c) 2013 IBRO. Published by Elsevier Ltd. All rights reserved."
     ],
     "FAU": [
          "Zugno, A I",
          "de Miranda, I M",
          "Budni, J",
          "Volpato, A M",
          "Luca, R D",
          "Deroza, P F",
          "de Oliveira, M B",
          "Heylmann, A S",
          "da Rosa Silveira, F",
          "Wessler, P",
          "Antunes Mastella, G",
          "Cipriano, A L",
          "Quevedo, J"
     ],
     "AU": [
          "Zugno AI",
          "de Miranda IM",
          "Budni J",
          "Volpato AM",
          "Luca RD",
          "Deroza PF",
          "de Oliveira MB",
          "Heylmann AS",
          "da Rosa Silveira F",
          "Wessler P",
          "Antunes Mastella G",
          "Cipriano AL",
          "Quevedo J"
     ],
     "AD": "Laboratorio de Neurociencias, Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), and Nucleo de Excelencia em Neurociencias Aplicadas de Santa Catarina (NENASC), Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, 88806-000 Criciuma, SC, Brazil. Electronic address: alz@unesc.net. Laboratorio de Neurociencias, Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), and Nucleo de Excelencia em Neurociencias Aplicadas de Santa Catarina (NENASC), Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, 88806-000 Criciuma, SC, Brazil. Laboratorio de Neurociencias, Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), and Nucleo de Excelencia em Neurociencias Aplicadas de Santa Catarina (NENASC), Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, 88806-000 Criciuma, SC, Brazil. Laboratorio de Neurociencias, Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), and Nucleo de Excelencia em Neurociencias Aplicadas de Santa Catarina (NENASC), Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, 88806-000 Criciuma, SC, Brazil. Laboratorio de Neurociencias, Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), and Nucleo de Excelencia em Neurociencias Aplicadas de Santa Catarina (NENASC), Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, 88806-000 Criciuma, SC, Brazil. Laboratorio de Neurociencias, Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), and Nucleo de Excelencia em Neurociencias Aplicadas de Santa Catarina (NENASC), Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, 88806-000 Criciuma, SC, Brazil. Laboratorio de Neurociencias, Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), and Nucleo de Excelencia em Neurociencias Aplicadas de Santa Catarina (NENASC), Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, 88806-000 Criciuma, SC, Brazil. Laboratorio de Neurociencias, Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), and Nucleo de Excelencia em Neurociencias Aplicadas de Santa Catarina (NENASC), Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, 88806-000 Criciuma, SC, Brazil. Laboratorio de Neurociencias, Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), and Nucleo de Excelencia em Neurociencias Aplicadas de Santa Catarina (NENASC), Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, 88806-000 Criciuma, SC, Brazil. Laboratorio de Neurociencias, Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), and Nucleo de Excelencia em Neurociencias Aplicadas de Santa Catarina (NENASC), Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, 88806-000 Criciuma, SC, Brazil. Laboratorio de Neurociencias, Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), and Nucleo de Excelencia em Neurociencias Aplicadas de Santa Catarina (NENASC), Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, 88806-000 Criciuma, SC, Brazil. Laboratorio de Neurociencias, Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), and Nucleo de Excelencia em Neurociencias Aplicadas de Santa Catarina (NENASC), Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, 88806-000 Criciuma, SC, Brazil. Laboratorio de Neurociencias, Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), and Nucleo de Excelencia em Neurociencias Aplicadas de Santa Catarina (NENASC), Programa de Pos-Graduacao em Ciencias da Saude, Unidade Academica de Ciencias da Saude, Universidade do Extremo Sul Catarinense, 88806-000 Criciuma, SC, Brazil.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20130614",
     "PL": "United States",
     "TA": "Neuroscience",
     "JT": "Neuroscience",
     "JID": "7605074",
     "RN": [
          "690G0D6V8H (Ketamine)",
          "EC 3.1.1.7 (Acetylcholinesterase)"
     ],
     "SB": "IM",
     "MH": [
          "Acetylcholinesterase/*metabolism",
          "Aging/*psychology",
          "Animals",
          "Avoidance Learning",
          "*Behavior, Animal",
          "Disease Models, Animal",
          "Ketamine/toxicity",
          "Locomotion",
          "Male",
          "*Maternal Deprivation",
          "Memory",
          "Motor Activity",
          "Rats",
          "Schizophrenia/chemically induced/*metabolism",
          "*Schizophrenic Psychology",
          "Social Behavior"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "acetylcholinesterase",
          "ketamine",
          "locomotor activity",
          "maternal deprivation",
          "memory",
          "schizophrenia"
     ],
     "EDAT": "2013/06/19 06:00",
     "MHDA": "2015/11/04 06:00",
     "CRDT": [
          "2013/06/18 06:00"
     ],
     "PHST": [
          "2013/01/17 00:00 [received]",
          "2013/05/28 00:00 [revised]",
          "2013/05/30 00:00 [accepted]",
          "2013/06/18 06:00 [entrez]",
          "2013/06/19 06:00 [pubmed]",
          "2015/11/04 06:00 [medline]"
     ],
     "AID": [
          "S0306-4522(13)00492-2 [pii]",
          "10.1016/j.neuroscience.2013.05.059 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neuroscience. 2013 Sep 17;248:252-60. doi: 10.1016/j.neuroscience.2013.05.059. Epub 2013 Jun 14.",
     "term": "hippocampus"
}